SCHEMBL56626

SCHEMBL56626

C[CH]C(C)(C)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL56177 0.81
SCHEMBL9858335 0.79 TSHR (0.37)
SCHEMBL28111389 0.77 TSHR (0.42)
SCHEMBL28062516 0.77 TSHR (0.42)
SCHEMBL11669918 0.77 TSHR (0.42)
SCHEMBL11525822 0.75
SCHEMBL57087 0.72
SCHEMBL270060 0.71
SCHEMBL3551576 0.71
SCHEMBL277708 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130087745-A1 SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS PRECURSOR ENERGETICS, INC. (US) 2013-04-11 US claimed
JP-4237257-B2 2009-03-11 JP claimed
EP-1021388-B1 PHOSPHORYLATION PROCESS AND CATALYST BIONERIS AB (SE) 2003-06-25 EP claimed
US-6479656-B1 Phosphorylation process and catalyst PERSTORP AB (SE) 2002-11-12 US claimed
JP-2001501910-A 2001-02-13 JP claimed
EP-1021388-A1 PHOSPHORYLATION PROCESS AND CATALYST PERSTORP AB (SE) 2000-07-26 EP claimed
WO-1997034853-A1 PHOSPHORYLATION PROCESS AND CATALYST PERSTORP AB (SE) 1997-09-25 WO claimed
US-20240174947-A1 SURFACTANT COMPOSITIONS LANKEM LTD. (GB) 2024-05-30 US disclosed
EP-4373529-A1 FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF 3B Pharmaceuticals GmbH (DE) 2024-05-29 EP disclosed
US-20240115745-A1 COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2024-04-11 US disclosed
CN-117769443-A Fibroblast activation protein inhibitor and use thereof 3B制药有限公司 2024-03-26 CN disclosed
WO-2024052431-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2024-03-14 WO disclosed
WO-2024043246-A1 ANION EXCHANGE-TYPE POLYMER ELECTROLYTE MEMBRANE, WATER ELECTROLYSIS DEVICE, CARBON DIOXIDE ELECTROLYSIS DEVICE, FUEL CELL, AND PRODUCTION METHOD FOR ANION EXCHANGE-TYPE POLYMER ELECTROLYTE MEMBRANE 三井化学株式会社 2024-02-29 WO disclosed
US-6106999-A SENSITIVITY TO GENERAL-PURPOSE VISIBLE LIGHT LASER, SO THAT HIGH-SPEED SCANNING EXPOSURE IS POSSIBLE BY LASER, AND EXTREMELY FINE HIGH RESOLUTION CAN BE OBTAINED; CAN BE USED FOR COATING OR PRINTING UNDER SAFELIGHT IRRADIATING CONDITIONS MITSUI CHEMICALS (JP) 2000-08-22 US disclosed
EP-1021388-A1 PHOSPHORYLATION PROCESS AND CATALYST PERSTORP AB (SE) 2000-07-26 EP disclosed
US-5886108-A Process for hydrogenating conjugated diene polymer ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1999-03-23 US disclosed
EP-0889057-A1 Process for hydrogenating conjugated diene polymer ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1999-01-07 EP disclosed
EP-0818512-A1 Quinoline derivative and use of same MITSUI TOATSU CHEMICALS, Inc. (JP) 1998-01-14 EP disclosed
WO-1997034853-A1 PHOSPHORYLATION PROCESS AND CATALYST PERSTORP AB (SE) 1997-09-25 WO disclosed
CN-87103208-A PHOSPHORAMIDO COMPOUNDS 1988-08-17 CN disclosed